Medical use of psilocybin
C-286 An act to amend the Controlled Drugs and Substances Act and the Food and Drugs Act
Allows psilocin and psilocybin for medical treatment under narcotic rules and automatically approves priority reviews for some new drugs.
What Bill C-286 would do
The bill would amend federal drug laws to allow psilocin and psilocybin to be used for medical treatment under the Narcotic Control Regulations. It would also automatically approve requests for priority review for certain new drugs. The published material gives no further detail.
Official summary
This enactment amends the Controlled Drugs and Substances Act and the Food and Drugs Act to allow psilocin and psilocybin to be used for medical treatment in accordance with the Narcotic Control Regulations . It also provides for the automatic approval of requests for priority review for certain new drugs.
- Kind
- Private member's bill
- Sponsor
- Corey Tochor, Member of Parliament (Saskatoon East)
- Introduced
- in the House of Commons
- Last activity
Where it stands
- ProposedJun 16 Exact stageOutside the Order of Precedence · since June 16, 2026Introduced, but not debated yet.
- Being debated
- Almost law
- Law
Waiting its turn; not scheduled for debate
-
First reading in the House done
Before the House on 1 sitting day,
-
Second reading in the House now
-
Committee in the House not yet
-
Report stage in the House not yet
-
Third reading in the House not yet
-
First reading in the Senate not yet
-
Second reading in the Senate not yet
-
Third reading in the Senate not yet
-
Royal assent not yet
Exact procedural stages
-
House
- First reading in the House: done, 2026-06-16
- Second reading in the House: current stage
- Committee in the House: not yet reached
- Report stage in the House: not yet reached
- Third reading in the House: not yet reached
-
Senate
- First reading in the Senate: not yet reached
- Second reading in the Senate: not yet reached
- Third reading in the Senate: not yet reached
-
Royal assent
- Royal assent: not yet reached
Debates in the House 0
No debate on this bill is in the record we hold yet.